A blocking peptide containing 19 amino acids near the amino terminus of human NALP13.
Points forts
Source
Synthetic
(Accession #: EAW72420) The NLRP13 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-048415 |
|---|
| Réf. fabricant | 18269525 |
|---|
| Gene ID (Entrez) | 126204 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-76294. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | CLR19.7, leucine rich repeat and pyrin domain containing 13, NACHT, leucine rich repeat and PYD containing 13, NACHT, LRR and PYD containing protein 13, NACHT, LRR and PYD domains-containing protein 13, NALP13, NLR family, pyrin domain containing 13, NOD14, nucleotide-binding oligomerization domain protein 14, PAN13 |
|---|
| Symbole de gène(s) | NLRP13 |
|---|
| Type de produit | NLRP13 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 19 amino acids near the amino terminus of human NALP13 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
